Back to: products

Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others)

PrintEmail
Dec 2022 - 183 Pages - From $3,390
(Excel Data Sheet: $2,000)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. 
Highlighted with 83 tables and 97 figures, this 183-page report “Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
 
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure 
• Growth Drivers 
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Region. 
 
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Consumables
• Analyzers/Instruments
 
Based on Prescription, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Professional Diagnostics
• OTC Based Testing
 
By Platform, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Immunoassays
o Lateral Flow Assays
o Serological Assays
o Other Immunoassays
• Molecular Detection
o Polymerase Chain Reaction (PCR)
o Other Molecular Detection Tests
• Other Platforms
 
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Blood Glucose Testing
• Cardiometabolic Testing
• Infectious Disease Testing
o COVID-19 Testing
o Healthcare-associated Infections (HAI) Testing
o Hepatitis Testing 
o Tropical Diseases Testing
o HIV Testing
o Influenza Testing
o Sexually Transmitted Diseases (STD) Testing
o Other Infectious Diseases Testing
• Blood Coagulation Testing
• Hematology Testing
• Cancer Testing
• Drug Abuse Testing
• Pregnancy & Fertility Testing
• Other Applications
 
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Hospitals & Clinics
• Laboratories
• Individuals/Homecare
• Other End Users
 
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Prescription and Application over the forecast years are also included.
 
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players: 
Abbott Diagnostics
ACON Laboratories
Becton Dickinson and Co.
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems
Danaher Corp.
F. Hoffmann La Roche Ltd.
GlySens Inc.
Meridian Bioscience Inc.
OraSure Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech Plc 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
 
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Global Market by Product 46
3.1 Market Overview by Product 46
3.2 Consumables 48
3.3 Analyzers/Instruments 49
4 Segmentation of Global Market by Prescription 50
4.1 Market Overview by Prescription 50
4.2 Professional Diagnostics 52
4.3 OTC Based Testing 53
5 Segmentation of Global Market by Platform 54
5.1 Market Overview by Platform 54
5.2 Immunoassays 56
5.2.1 Lateral Flow Assays 58
5.2.2 Serological Assays 59
5.2.3 Other Immunoassays 60
5.3 Molecular Detection 61
5.3.1 Polymerase Chain Reaction (PCR) 62
5.3.2 Other Molecular Detection Tests 63
5.4 Other Platforms 64
6 Segmentation of Global Market by Application 65
6.1 Market Overview by Application 65
6.2 Blood Glucose Testing 67
6.3 Cardiometabolic Testing 68
6.4 Infectious Disease Testing 69
6.4.1 COVID-19 Testing 71
6.4.2 Healthcare-associated Infections (HAI) Testing 72
6.4.3 Hepatitis Testing 73
6.4.4 Tropical Diseases Testing 74
6.4.5 HIV Testing 75
6.4.6 Influenza Testing 76
6.4.7 Sexually Transmitted Diseases (STD) Testing 77
6.4.8 Other Infectious Diseases Testing 78
6.5 Blood Coagulation Testing 79
6.6 Hematology Testing 80
6.7 Cancer Testing 81
6.8 Drug Abuse Testing 82
6.9 Pregnancy & Fertility Testing 83
6.10 Other Applications 84
7 Segmentation of Global Market by End User 85
7.1 Market Overview by End User 85
7.2 Hospitals & Clinics 87
7.3 Laboratories 88
7.4 Individuals/Homecare 89
7.5 Other End Users 90
8 Segmentation of Global Market by Region 91
8.1 Geographic Market Overview 2021-2031 91
8.2 North America Market 2021-2031 by Country 95
8.2.1 Overview of North America Market 95
8.2.2 U.S. 99
8.2.3 Canada 102
8.2.4 Mexico 104
8.3 European Market 2021-2031 by Country 106
8.3.1 Overview of European Market 106
8.3.2 Germany 110
8.3.3 U.K. 112
8.3.4 France 114
8.3.5 Spain 116
8.3.6 Italy 118
8.3.7 Netherlands 120
8.3.8 Rest of European Market 122
8.4 Asia-Pacific Market 2021-2031 by Country 124
8.4.1 Overview of Asia-Pacific Market 124
8.4.2 Japan 128
8.4.3 China 131
8.4.4 Australia 133
8.4.5 India 135
8.4.6 South Korea 137
8.4.7 Rest of APAC Region 139
8.5 South America Market 2021-2031 by Country 141
8.5.1 Argentina 144
8.5.2 Brazil 146
8.5.3 Chile 148
8.5.4 Rest of South America Market 150
8.6 MEA Market 2021-2031 by Country 151
8.6.1 UAE 154
8.6.2 Saudi Arabia 156
8.6.3 South Africa 158
8.6.4 Other National Markets 160
9 Competitive Landscape 161
9.1 Overview of Key Vendors 161
9.2 New Product Launch, Partnership, Investment, and M&A 166
9.3 Company Profiles 168
Abbott Diagnostics 168
ACON Laboratories 170
Becton Dickinson and Co. 171
BioMérieux S.A. 172
Bio-Rad Laboratories, Inc. 173
Chembio Diagnostic Systems 174
Danaher Corp. 175
F. Hoffmann La Roche Ltd. 176
GlySens Inc. 177
Meridian Bioscience Inc. 178
OraSure Technologies Inc. 179
Siemens Healthineers AG 180
Thermo Fisher Scientific Inc. 181
Trinity Biotech Plc 182
RELATED REPORTS 183
List of Tables:
 
Table 1.  Snapshot of Global Rapid Diagnostics Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 24
Table 3. World Economic Outlook, 2021-2023 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 34
Table 5.  Main Product Trends and Market Opportunities in Global Rapid Diagnostics Market 38
Table 6. Global Rapid Diagnostics Market by Product, 2021-2031, $ mn 46
Table 7. Global Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 50
Table 8. Global Rapid Diagnostics Market by Platform, 2021-2031, $ mn 54
Table 9. Global Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn 57
Table 10. Global Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn 61
Table 11. Global Rapid Diagnostics Market by Application, 2021-2031, $ mn 65
Table 12. Global Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn 70
Table 13. Global Rapid Diagnostics Market by End User, 2021-2031, $ mn 85
Table 14. Global Rapid Diagnostics Market by Region, 2021-2031, $ mn 92
Table 15.  Leading National Rapid Diagnostics Market, 2021 and 2031, $ mn 94
Table 16. North America Rapid Diagnostics Market by Country, 2021-2031, $ mn 97
Table 17. U.S. Rapid Diagnostics Market by Product, 2021-2031, $ mn 101
Table 18. U.S. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 101
Table 19. U.S. Rapid Diagnostics Market by Application, 2021-2031, $ mn 101
Table 20. Canada Rapid Diagnostics Market by Product, 2021-2031, $ mn 103
Table 21. Canada Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 103
Table 22. Canada Rapid Diagnostics Market by Application, 2021-2031, $ mn 103
Table 23. Mexico Rapid Diagnostics Market by Product, 2021-2031, $ mn 105
Table 24. Mexico Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 105
Table 25. Mexico Rapid Diagnostics Market by Application, 2021-2031, $ mn 105
Table 26. Europe Rapid Diagnostics Market by Country, 2021-2031, $ mn 109
Table 27. Germany Rapid Diagnostics Market by Product, 2021-2031, $ mn 111
Table 28. Germany Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 111
Table 29. Germany Rapid Diagnostics Market by Application, 2021-2031, $ mn 111
Table 30. U.K. Rapid Diagnostics Market by Product, 2021-2031, $ mn 113
Table 31. U.K. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 113
Table 32. U.K. Rapid Diagnostics Market by Application, 2021-2031, $ mn 113
Table 33. France Rapid Diagnostics Market by Product, 2021-2031, $ mn 115
Table 34. France Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 115
Table 35. France Rapid Diagnostics Market by Application, 2021-2031, $ mn 115
Table 36. Spain Rapid Diagnostics Market by Product, 2021-2031, $ mn 117
Table 37. Spain Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 117
Table 38. Spain Rapid Diagnostics Market by Application, 2021-2031, $ mn 117
Table 39. Italy Rapid Diagnostics Market by Product, 2021-2031, $ mn 119
Table 40. Italy Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 119
Table 41. Italy Rapid Diagnostics Market by Application, 2021-2031, $ mn 119
Table 42. Netherlands Rapid Diagnostics Market by Product, 2021-2031, $ mn 121
Table 43. Netherlands Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 121
Table 44. Netherlands Rapid Diagnostics Market by Application, 2021-2031, $ mn 121
Table 45. Rapid Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 123
Table 46. APAC Rapid Diagnostics Market by Country, 2021-2031, $ mn 126
Table 47. Japan Rapid Diagnostics Market by Product, 2021-2031, $ mn 130
Table 48. Japan Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 130
Table 49. Japan Rapid Diagnostics Market by Application, 2021-2031, $ mn 130
Table 50. China Rapid Diagnostics Market by Product, 2021-2031, $ mn 132
Table 51. China Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 132
Table 52. China Rapid Diagnostics Market by Application, 2021-2031, $ mn 132
Table 53. Australia Rapid Diagnostics Market by Product, 2021-2031, $ mn 134
Table 54. Australia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 134
Table 55. Australia Rapid Diagnostics Market by Application, 2021-2031, $ mn 134
Table 56. India Rapid Diagnostics Market by Product, 2021-2031, $ mn 136
Table 57. India Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 136
Table 58. India Rapid Diagnostics Market by Application, 2021-2031, $ mn 136
Table 59. South Korea Rapid Diagnostics Market by Product, 2021-2031, $ mn 138
Table 60. South Korea Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 138
Table 61. South Korea Rapid Diagnostics Market by Application, 2021-2031, $ mn 138
Table 62. Rapid Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 140
Table 63. South America Rapid Diagnostics Market by Country, 2021-2031, $ mn 143
Table 64. Argentina Rapid Diagnostics Market by Product, 2021-2031, $ mn 145
Table 65. Argentina Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 145
Table 66. Argentina Rapid Diagnostics Market by Application, 2021-2031, $ mn 145
Table 67. Brazil Rapid Diagnostics Market by Product, 2021-2031, $ mn 147
Table 68. Brazil Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 147
Table 69. Brazil Rapid Diagnostics Market by Application, 2021-2031, $ mn 147
Table 70. Chile Rapid Diagnostics Market by Product, 2021-2031, $ mn 149
Table 71. Chile Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 149
Table 72. Chile Rapid Diagnostics Market by Application, 2021-2031, $ mn 149
Table 73. MEA Rapid Diagnostics Market by Country, 2021-2031, $ mn 153
Table 74. UAE Rapid Diagnostics Market by Product, 2021-2031, $ mn 155
Table 75. UAE Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 155
Table 76. UAE Rapid Diagnostics Market by Application, 2021-2031, $ mn 155
Table 77. Saudi Arabia Rapid Diagnostics Market by Product, 2021-2031, $ mn 157
Table 78. Saudi Arabia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 157
Table 79. Saudi Arabia Rapid Diagnostics Market by Application, 2021-2031, $ mn 157
Table 80. South Africa Rapid Diagnostics Market by Product, 2021-2031, $ mn 159
Table 81. South Africa Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 159
Table 82. South Africa Rapid Diagnostics Market by Application, 2021-2031, $ mn 159
Table 83. Rapid Diagnostic Analyzers by Vendor 163
Table 84. Recent Product Launches, 2018-2021 167
Table 85. Abbott Diagnostics: Company Snapshot 168
Table 86. Abbott Diagnostics: Business Segmentation 169
Table 87. Abbott Diagnostics: Product Portfolio 169
 
 
 
 
List of Figures:
 
Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global Rapid Diagnostics Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global Rapid Diagnostics Market 29
Figure 7.  Leading Causes of Death in the World, 2000 and 2019, million 32
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 10. Primary Restraints and Impact Factors of Global Rapid Diagnostics Market 35
Figure 11. Investment Opportunity Analysis 39
Figure 12. Porter’s Fiver Forces Analysis of Global Rapid Diagnostics Market 42
Figure 13. Breakdown of Global Rapid Diagnostics Market by Product, 2021-2031, % of Revenue 47
Figure 14. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 47
Figure 15. Global Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn 48
Figure 16. Global Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn 49
Figure 17. Breakdown of Global Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue 51
Figure 18. Global Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%) 51
Figure 19. Global Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn 52
Figure 20. Global Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn 53
Figure 21. Breakdown of Global Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue 55
Figure 22. Global Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%) 55
Figure 23. Global Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn 56
Figure 24. Global Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn 58
Figure 25. Global Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn 59
Figure 26. Global Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn 60
Figure 27. Global Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn 61
Figure 28. Global Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 62
Figure 29. Global Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn 63
Figure 30. Global Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn 64
Figure 31. Breakdown of Global Rapid Diagnostics Market by Application, 2021-2031, % of Revenue 66
Figure 32. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 66
Figure 33. Global Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn 67
Figure 34. Global Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn 68
Figure 35. Global Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn 69
Figure 36. Global Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn 71
Figure 37. Global Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn 72
Figure 38. Global Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn 73
Figure 39. Global Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn 74
Figure 40. Global Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn 75
Figure 41. Global Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn 76
Figure 42. Global Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn 77
Figure 43. Global Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn 78
Figure 44. Global Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn 79
Figure 45. Global Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn 80
Figure 46. Global Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn 81
Figure 47. Global Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn 82
Figure 48. Global Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn 83
Figure 49. Global Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 84
Figure 50. Breakdown of Global Rapid Diagnostics Market by End User, 2021-2031, % of Revenue 86
Figure 51. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 86
Figure 52. Global Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn 87
Figure 53. Global Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn 88
Figure 54. Global Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn 89
Figure 55. Global Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 90
Figure 56.  Global Market Snapshot by Region 91
Figure 57.  Geographic Spread of Worldwide Rapid Diagnostics Market, 2021-2031, % of Sales Revenue 92
Figure 58. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 93
Figure 59.  North American Rapid Diagnostics Market, 2021-2031, $ mn 96
Figure 60. Breakdown of North America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 97
Figure 61. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 98
Figure 62. U.S. Rapid Diagnostics Market, 2021-2031, $ mn 100
Figure 63. Canada Rapid Diagnostics Market, 2021-2031, $ mn 102
Figure 64.  Rapid Diagnostics Market in Mexico, 2021-2031, $ mn 104
Figure 65.  European Rapid Diagnostics Market, 2021-2031, $ mn 107
Figure 66. Breakdown of European Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 108
Figure 67. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 109
Figure 68.  Rapid Diagnostics Market in Germany, 2021-2031, $ mn 110
Figure 69.  Rapid Diagnostics Market in U.K., 2021-2031, $ mn 112
Figure 70.  Rapid Diagnostics Market in France, 2021-2031, $ mn 114
Figure 71.  Rapid Diagnostics Market in Spain, 2021-2031, $ mn 116
Figure 72.  Rapid Diagnostics Market in Italy, 2021-2031, $ mn 118
Figure 73.  Rapid Diagnostics Market in Netherlands, 2021-2031, $ mn 120
Figure 74.  Rapid Diagnostics Market in Rest of Europe, 2021-2031, $ mn 122
Figure 75. Asia-Pacific Rapid Diagnostics Market, 2021-2031, $ mn 125
Figure 76. Breakdown of APAC Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 125
Figure 77. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 127
Figure 78.  Rapid Diagnostics Market in Japan, 2021-2031, $ mn 129
Figure 79.  Rapid Diagnostics Market in China, 2021-2031, $ mn 131
Figure 80.  Rapid Diagnostics Market in Australia, 2021-2031, $ mn 133
Figure 81.  Rapid Diagnostics Market in India, 2021-2031, $ mn 135
Figure 82.  Rapid Diagnostics Market in South Korea, 2021-2031, $ mn 137
Figure 83.  Rapid Diagnostics Market in Rest of APAC, 2021-2031, $ mn 139
Figure 84. South America Rapid Diagnostics Market, 2021-2031, $ mn 142
Figure 85. Breakdown of South America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 142
Figure 86. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 143
Figure 87.  Rapid Diagnostics Market in Argentina, 2021-2031, $ mn 144
Figure 88.  Rapid Diagnostics Market in Brazil, 2021-2031, $ mn 146
Figure 89.  Rapid Diagnostics Market in Chile, 2021-2031, $ mn 148
Figure 90.  Rapid Diagnostics Market in Rest of South America, 2021-2031, $ mn 150
Figure 91. Rapid Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn 152
Figure 92. Breakdown of MEA Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 152
Figure 93. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 153
Figure 94.  Rapid Diagnostics Market in UAE, 2021-2031, $ mn 154
Figure 95.  Rapid Diagnostics Market in Saudi Arabia, 2021-2031, $ mn 156
Figure 96.  Rapid Diagnostics Market in South Africa, 2021-2031, $ mn 158
Figure 97. Growth Stage of Global Rapid Diagnostics Industry over the Forecast Period 161
 

 

 

Reviews

There are yet no reviews for this product.